These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27071408)

  • 21. Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation.
    Hsu JC; Chan PS; Tang F; Maddox TM; Marcus GM
    Am J Med; 2015 Jun; 128(6):654.e1-654.e10. PubMed ID: 25554371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Direct Oral Anticoagulants in Canadian Primary Care Practice 2010-2015: A Cohort Study From the Canadian Primary Care Sentinel Surveillance Network.
    McAlister FA; Garrison S; Kosowan L; Ezekowitz JA; Singer A
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
    Camm AJ; Accetta G; Ambrosio G; Atar D; Bassand JP; Berge E; Cools F; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G; Koretsune Y; Mantovani LG; Misselwitz F; Oh S; Turpie AG; Verheugt FW; Kakkar AK;
    Heart; 2017 Feb; 103(4):307-314. PubMed ID: 27647168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study.
    Biteker M; Başaran Ö; Doğan V; Altun İ; Özpamuk Karadeniz F; Tekkesin Aİ; Çakıllı Y; Türkkan C; Hamidi M; Demir V; Gürsoy MO; Tek Öztürk M; Aksan G; Seyis S; Ballı M; Alıcı MH; Bozyel S
    J Am Geriatr Soc; 2017 Aug; 65(8):1684-1690. PubMed ID: 28394435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.
    Başaran Ö; Dogan V; Beton O; Tekinalp M; Aykan AÇ; Kalaycıoğlu E; Bolat I; Taşar O; Şafak Ö; Kalçık M; Yaman M; İnci S; Altıntaş B; Kalkan S; Kırma C; Biteker M;
    J Thromb Thrombolysis; 2017 Feb; 43(2):157-165. PubMed ID: 27848065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary artery disease in outpatients with nonvalvular atrial fibrillation: results from the multicenter RAMSES study.
    Dogan V; Başaran Ö; Beton O; Tekinalp M; Bolat I; Kalaycioğlu E; Aykan AÇ; Taşar O; Şafak Ö; Kalçik M; Yaman M; Kirma C; Biteker M
    Coron Artery Dis; 2016 Sep; 27(6):497-503. PubMed ID: 27182772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation.
    Deguchi I; Ogawa H; Ohe Y; Nemoto M; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):846-50. PubMed ID: 22819543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonadherence to guidelines for prescribing antiplatelet/anticoagulant therapy in patients with atrial fibrillation.
    Navarro-Juan M; Carbonell-Torregrosa MÁ; Palazón-Bru A; Martínez-Díaz AM; Gil-Guillén VF
    Fam Pract; 2016 Jun; 33(3):290-5. PubMed ID: 27006412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation.
    Spivey CA; Qiao Y; Liu X; Mardekian J; Parker RB; Phatak H; Claflin AB; Kachroo S; Abdulsattar Y; Chakrabarti A; Wang J
    J Manag Care Spec Pharm; 2015 Jul; 21(7):596-606. PubMed ID: 26108384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal Dysfunction, CHADS
    Sun Y; Wang Y; Jiang J; Wang L; Hu D
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):248-254. PubMed ID: 26467322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and early anticoagulation in patients with atrial fibrillation in the emergency department.
    Schwab K; Smith R; Wager E; Kaur S; Alvarez L; Wagner J; Leung H
    Am J Emerg Med; 2021 Jun; 44():315-322. PubMed ID: 32331958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing Stroke Prevention in Patients With Atrial Fibrillation: A Cluster-Randomized Controlled Trial of a Computerized Antithrombotic Risk Assessment Tool in Australian General Practice, 2012-2013.
    Bajorek BV; Magin PJ; Hilmer SN; Krass I
    Prev Chronic Dis; 2016 Jul; 13():E90. PubMed ID: 27418212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic Usage Patterns in the Era of New Oral Anticoagulant Options for Atrial Fibrillation.
    Marler J; Usery JB; Nolan S; Oliphant CS
    Hosp Pharm; 2016 Jul; 51(7):564-71. PubMed ID: 27559189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anticoagulation choices of internal medicine residents for stroke prevention in non-valvular atrial fibrillation.
    Moulson N; McIntyre WF; Oqab Z; Yazdan-Ashoori P; Quinn KL; van Oosten E; Hopman WM; Baranchuk A
    Postgrad Med J; 2017 Jun; 93(1100):308-312. PubMed ID: 27307471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
    Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHA
    Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
    Gullón A; Suárez C; Díez-Manglano J; Formiga F; Cepeda JM; Pose A; Camafort M; Castiella J; Rovira E; Mostaza JM;
    Med Clin (Barc); 2017 Mar; 148(5):204-210. PubMed ID: 27993408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.